JESSICA JONES: Open Payments
NPI 1174397509 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$379 in 10 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $418 · 2025 $379
Food & beverage: $379
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $182 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $125 |
| Rhythm Pharmaceuticals, Inc. | 2 | $51 |
| Janssen Biotech, Inc. | 1 | $21 |
Products named: ENTYVIO, Ozempic, Wegovy, IMCIVREE, TREMFYA.
Industry payments across OK — which companies pay providers there.
